Huvitz Co., Ltd. (KOSDAQ:065510)
South Korea · Delayed Price · Currency is KRW
8,070.00
+100.00 (1.25%)
At close: Apr 16, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Ophthalmic Medical Device Business | | | 117.74B | - | - | - | - | | | |
| | | - | - | 100.98B | 70.14B | 95.58B | | | |
Manufacturing Business Growth | | | - | - | 43.97% | -26.62% | 11.70% | | | |
| | | - | - | 3.28B | 7.08B | 2.22B | | | |
Financial Investment Growth | | | - | - | -53.67% | 218.88% | -10.12% | | | |
| | | - | - | -9.24B | -7.13B | -9.82B | | | |
| | | 117.74B | - | 95.02B | 70.09B | 87.99B | | | |
| | | - | - | 35.57% | -20.34% | 11.57% | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 17.33B | 16.88B | 14.87B | - | - | | | |
| | | 2.63% | 13.55% | - | - | - | | | |
| | | 53.40B | 46.94B | 38.91B | - | - | | | |
| | | 13.77% | 20.62% | - | - | - | | | |
| | | 43.28B | 39.97B | 25.02B | - | - | | | |
| | | 8.27% | 59.79% | - | - | - | | | |
| | | 3.73B | 4.99B | 4.07B | - | - | | | |
| | | -25.27% | 22.59% | - | - | - | | | |
| | | - | - | 12.15B | - | - | | | |
| | | 117.74B | 108.78B | 95.02B | - | - | | | |
| | | 8.23% | 14.48% | - | - | - | | | |
Source: S&P Global Market Intelligence.